|Min SIP Amount||Not Supported|
|NAV||₹11.73 (28 Jul 2020)|
|Fund Started||27 Jan 2017|
|Fund Size||₹56 Cr|
|Bajaj Finance Ltd.||Financial||Debenture||7.4%|
|Uttar Pradesh State||Others||SDL||1.8%|
|Dr. Reddy's Laboratories Ltd.||Healthcare||Equity||0.9%|
|HDFC Bank Ltd.||Financial||Equity||0.8%|
|National Thermal Power Corp. Ltd.||Energy||Equity||0.5%|
|Sun Pharmaceutical Inds. Ltd.||Healthcare||Equity||0.5%|
|Torrent Power Ltd.||Energy||Equity||0.5%|
|Maruti Suzuki India Ltd.||Automobile||Equity||0.4%|
UTI Dual Advantage Fixed Term Fund Series IV II (1278 Days) Regular Growth is a Hybrid Mutual Fund Scheme launched by Axis Mutual Fund. This scheme was made available to investors on 27 Jan 2017. V Srivatsa, Sunil Patil is the Current Fund Manager of UTI Dual Advantage Fixed Term Fund Series IV II (1278 Days) Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹56 Cr and the Latest NAV as of 28 Jul 2020 is ₹11.73.
The UTI Dual Advantage Fixed Term Fund Series IV II (1278 Days) Regular Growth is rated Moderately High risk.
The scheme aims to generate returns by investing in a portfolio of fixed income securities maturing on or before the date of maturity of the scheme. However, the scheme does not guarantee / indicate any return. There is no assurance that the funds objective will be achieved.